OC50 2025: Bobak “Bobby” Azamian
Bobby Azamian BOBAK “BOBBY” AZAMIAN CEO/CHAIRMAN / CO-FOUNDER TARSUS PHARMACEUTICALS WHY: Spearheaded the development and commercialization of Xdemvy, the first FDA-approved treatment for Demodex blepharitis, an inflammation of the eyelids caused by mites. Raised $101M in IPO in 2020; company so successful that it was able to raise another $125M in Read More




